BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17161482)

  • 1. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA; Krause M; Zyromska A; Lambin P; Baumann M; Wouters BG
    Radiother Oncol; 2007 Jan; 82(1):96-104. PubMed ID: 17161482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.
    Eshleman JS; Carlson BL; Mladek AC; Kastner BD; Shide KL; Sarkaria JN
    Cancer Res; 2002 Dec; 62(24):7291-7. PubMed ID: 12499272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
    Sun LQ; Li YX; Guillou L; Coucke PA
    Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
    Schuuring J; Bussink J; Bernsen HJ; Peeters W; van Der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):529-34. PubMed ID: 15667976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature.
    Murphy JD; Spalding AC; Somnay YR; Markwart S; Ray ME; Hamstra DA
    Clin Cancer Res; 2009 Jan; 15(2):589-96. PubMed ID: 19147764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
    Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo.
    Krause M; Wohlfarth J; Georgi B; Pimentel N; Dorner D; Zips D; Eicheler W; Hessel F; Short SC; Joiner MC; Baumann M
    Int J Radiat Biol; 2005 Oct; 81(10):751-8. PubMed ID: 16449082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
    Krause M; Schütze C; Petersen C; Pimentel N; Hessel F; Harstrick A; Baumann M
    Radiother Oncol; 2005 Feb; 74(2):109-15. PubMed ID: 15734198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV; Bloomer WD; Hollingshead MG
    Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging study.
    Zeng Q; Yang Z; Gao YJ; Yuan H; Cui K; Shi Y; Wang H; Huang X; Wong ST; Wang Y; Kesari S; Ji RR; Xu X
    Eur J Cancer; 2010 Apr; 46(6):1132-43. PubMed ID: 20156674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation.
    Stüben G; Thews O; Pöttgen C; Knühmann K; Sack H; Stuschke M; Vaupel P
    Strahlenther Onkol; 2003 Sep; 179(9):620-5. PubMed ID: 14628128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.
    Manegold PC; Paringer C; Kulka U; Krimmel K; Eichhorn ME; Wilkowski R; Jauch KW; Guba M; Bruns CJ
    Clin Cancer Res; 2008 Feb; 14(3):892-900. PubMed ID: 18245553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
    Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
    Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.